Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Down 91.5% in November

Revolution Medicines, Inc. (NASDAQ:RVMDW) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 400 shares, a decrease of 91.5% from the October 31st total of 4,700 shares. Based on an average daily trading volume, of 35,900 shares, the days-to-cover ratio is presently 0.0 days.

Revolution Medicines Trading Up 2.6 %

Revolution Medicines stock traded up $0.01 during mid-day trading on Wednesday, reaching $0.40. The company had a trading volume of 89,430 shares, compared to its average volume of 18,743. The stock’s 50-day simple moving average is $0.27 and its 200-day simple moving average is $0.18. Revolution Medicines has a 1 year low of $0.03 and a 1 year high of $1.00.

Revolution Medicines Company Profile

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.